Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Andexanet alfa Reversal of Apixaban in Healthy Volunteers
NCT01758432Phase 2Completed
- Sponsor
- Portola Pharmaceuticals
- Start
- Dec 2012
- Primary completion
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of andexanet alfa in hemorrhage, sponsored by Portola Pharmaceuticals. Started Dec 2012; status: completed.
02
Drugs
andexanet alfa
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT01758432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01758432.